Davis Polk advised Morgan Stanley & Co. LLC, Goldman, Sachs & Co. and J.P. Morgan Securities LLC as the joint book runners on a $258.7 million SEC-registered offering of 51,750,000 shares of common stock of Molycorp, Inc. (Molycorp).
Herbert Smith Freehills has advised Goldman Sachs Australia Pty Ltd in relation to its role as sole lead manager and underwriter of FKP Property Group’s (FKP) underwritten A$232 million accelerated pro-rata non-renounceable entitlement offer announced on Monday (the Entitlement Offer) and in relation to its role as sole bookrunner and underwriter of Stockland’s sale of its stake in FKP, conducted concurrently with the institutional shortfall bookbuild under the Entitlement Offer.
DLA Piper has advised China Everbright Capital Limited and China Everbright Securities (HK) Limited, sole sponsor and sole lead manager, on the IPO of IGG Inc (IGG) on the GEM (Growth Enterprise Markets) Board of the Hong Kong Stock Exchange (stock code: 8002). The listing of 327,434,000 shares at a placing price of HK$2.80, together with the over-allocation during the bookbuilding process, raised more than HK$1 billion from the market.
Paul Hastings represented UBS as the sole global coordinator, sole bookrunner, sole lead manager and sole sponsor in China Huirong Financial Holdings Limited’s (“China Huirong”) US$ 106 million global offering and IPO on the Main Board of the Hong Kong Stock Exchange.
China Huirong is a leading short-term secured financing service provider in China that specializes in providing its customers with short-term loans secured by collateral.
Simpson Thacher recently represented the underwriters, led by sole book-running manager J.P. Morgan Securities LLC, in the initial public offering by Cellular Dynamics International, Inc. (“CDI”) of 3,846,000 shares of common stock. CDI’s common stock is listed on the Nasdaq Global Market under the ticker symbol “ICEL.”
Cellular Dynamics International, Inc. is a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications.
Herbert Smith Freehills advised Goldman Sachs (Asia) LLC as the placing agent on a US$294 million private placement of new H-shares in Chinese railway power equipment maker Zhuzhou CSR Times Electric Company Limited.
Proceeds from the shares placement will be used to buy raw materials and machinery.
Headquartered in Zhuzhou, Hunan, Zhuzhou CSR Times engages in the research, development, design, manufacture and sale of mass transit electric driver convertor and control systems in China.
Hogan Lovells has advised CLSA Limited ("CLSA") and CITIC Securities Corporate Finance (HK) Limited ("CITIC Securities") as the joint placing agents in respect of a placement of 115 million existing shares in Trigiant Group Limited ("Trigiant") for approximately HK$362.3 million (US$46 million). In addition, the same number of new shares was issued to its controlling shareholder Trigiant Investments Limited.
Paul Hastings LLP, a leading global law firm, has announced that it represented Grupo Lala, Mexico’s largest dairy company and one of the leading dairy companies in Latin America, in completing its $1.1 billion initial public offering of common stock. The offering is the largest IPO of the year from Latin America.
Squire Sanders has advised the full-service broking and advisory house and AIM nominated adviser Peel Hunt LLP, in relation to an equity fundraising by Peel Hunt’s client, Hydrodec Group plc. The fundraising involved an institutional placing, a placing with Hydrodec’s directors and an open offer to Hydrodec’s shareholders, with a view to raising up to £24 million. The funds raised will be used to re-pay Hydrodec’s existing debt and position the company for future growth. The fundraising is conditional on the approval of Hydrodec’s shareholders.
San Francisco, CA-- Paul Hastings LLP, a leading global law firm, announced today that it represented BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a pharmaceutical company that develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, in connection with its underwritten offering of $375,000,000 aggregate principal amount of its 0.75% Senior Subordinated Convertible Notes due 2018 and $375,000,000 aggregate principal amount of its 1.50% Senior Subordinated Convertible Notes due 2020.